#JITC Short Report: A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy https://t.co/4f3rpOj0lO https://t.co/4DeWzcrmkV
19,108 followers
19,108 followers
#JITC Short Report: A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy https://t.co/4f3rpOj0lO https://t.co/5TcsG6wzGn
734 followers
RT @MosheOrnsteinMD: Phase II trial of intermittent nivolumab in #RCC. Our #CleClinicCancer @CleClinicMD experience published in #JITC @sit…
610 followers
RT @DralexGva: Very interesting early/small scale data on intermittent nivo in RCC. @Alfdoc2, are any such trials active in lung/melanoma?…